ARAB HEALTH 20 2 2
will also use the show to meet and gain a better understanding of the needs of international healthcare systems with a view to helping them find NHS organisations and UK innovators with solutions that could help them. Finally, the Network are also keen to make contact with innovators from outside the UK who are interested in entering the UK market and are looking for support and advice to help them do this.
Axial3D’s AI-based Segmentation-as- a-Service platform is transforming how surgery is delivered, throughout the world, by turning hard-to-understand 2D medical scans of patient anatomy into precise and data-rich 3D visualisations and 3D-printed models. Globally, surgeons use Axial3D models for pre-operative planning, briefing the surgical team and for improving the patient consent process. The company’s research shows that 53% of physicians end up changing their surgical plans when using an Axial3D model. They also report an average of 62 minutes saved per case or $1,200 saved in costs. Patients in 98% of cases feel that a 3D anatomical model helps them better understand the treatment plan and the desired outcomes compared to using 2D medical scans alone in discussions with their surgeon. Axial3D’s mission is to transform the accuracy and speed of pre- operative planning, diagnosis and treatment for all patients around the world. They are looking to expand to the Middle East.
working with their UK-based subsidiary ProtecX to continue their tradition of craftsmanship and innovation for customers across the world. Their aim is to always work toward holistic radiation protection for providers. The manufacturer offers fully tailored aprons, as well as eyewear, gloves, barriers, drapes, and patient positioning solutions.
DCC Vital’s product portfolio includes a comprehensive range of sterile and non-sterile surgical consumables for the use throughout the hospital and healthcare setting. At this year’s exhibition, the company will be showcasing their extensive range of endoscopic and theatre essentials, as well as launching their new range of smoke evacuation solutions.
Durbin On Demand Access is a leading provider of access to pharmaceutical products, with expertise in speciality and unlicensed medicine. The business has developed lasting relationships with its large network of pharmaceutical manufacturers to be able to offer customers access to medicine from around the globe, with the ability to source and distribute products to over 160 countries.
B.N.O.S. Meditech – a British manufacturer of medical gas equipment – has specifically developed a low flow Oxygen flow meter for use with premature or low birthweight babies. The Meditech unit will be available in two flow ranges – 0 to 1 LPM and 0 to 3 LPM with highly accurate, pre-set flow rates. For use in all hospital and emergency environments the low flow meter comes with a five-year service interval, five-year manufacturer’s warranty and is claimed to never fall out of calibration. The device, which is being showcased at Arab Health, can be supplied with any international input probe required.
ProtecX Medical / Burlington Medical are experts in the safety concerns of providers working in radiation environments. The company engineers high quality lead aprons,
JANUARY 2022
Little Journey is an award-winning eSupport platform designed to psychologically prepare and support children and their families undergoing healthcare procedures from the comfort of their own home. The platform is suitable for use as part of routine care as well as supporting those participating in clinical trials. For organisations, Little Journey generates revenue through customer attraction and satisfaction with care, while also increasing organisation efficiency. For families, Little Journey improves children’s mental and physical wellbeing, enhances their experiences of care, and promotes positive health behaviour development. The Little Journey platform consists of a smartphone app delivering multi-faceted preparation and support for children and their parents, and a web-based hospital
portal enabling healthcare and research organisations to configure the app to their own local patient pathways and trial protocols. The Little Journey platform was founded by Dr. Chris Evans, an NHS doctor and researcher, based on his clinical and research experience. In 2021, Little Journey won the Patient Experience Network Innovation award and was appointed onto the NHS Innovation Accelerator to support its adoption across the NHS. The platform is configured to 50+ NHS hospitals with benefits such as 30% anxiety reduction, 42% lower on-the-day cancellation and 30% faster recovery.
Assistive technology developer Lusio Rehab UK will be launching its wearable rehabilitation device LusioMATE to the Middle East market. The device increases patient and user engagement with their rehabilitation by combining movements with the playing of fun video games. It enables the development of fine and gross motor skills, can be used almost anywhere on the body and even people who can only move a few millimeters can enjoy the games as much as someone with full movement. It was initially developed for children with cerebral palsy but is now being used to help patients of all ages with a range of conditions. The device enables users to do more rehabilitation in-between their therapist sessions and can be used for in-patients and follow patients through the rehabilitation pathway into home/community.
Medovate will be at Arab Health to showcase SAFIRA to Middle East audiences. This innovative technology transforms regional anaesthesia into a single operator procedure, giving anaesthetists full control of injection, as well as enhancing confidence through a built-in safety mechanism to automatically prevent injection above 20psi to reduce the risk of nerve injury. Already in
WWW.CLINICALSERVICESJOURNAL.COM l 39
▲
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84
